News
Sterling is getting a boost from a weak US dollar after the US Federal Reserve left rates unchanged, trading between $1.32 ...
British equities closed mixed on Thursday, as investors assessed a spate of corporate earnings and looked for potential trade ...
The Fed call was soon overtaken by the results from Microsoft and Meta Platforms, benefiting from the growth of artificial ...
FTSE 100 futures are about flat, compared to small gains across Europe and the US, as we await another batch of earnings. The ...
Shares in Rolls-Royce have spiked after the FTSE 100 giant revealed better-than-expected interim results this morning.
The biggest fallers on the FTSE 100 were Taylor Wimpey, down 6.7p at 100.45p, ConvaTec, down 13.40p at 231.0p, HSBC, down ...
Shell has endured a bruising period as oil prices see-sawed amid the White House's trade offensive and rising conflict in the ...
Britain's FTSE 100 closed higher on Tuesday, led by healthcare shares, as investors assessed mixed corporate updates and ...
Rolls-Royce has raised its profit guidance after a “strong start to the year” which saw its revenue surge by almost £1bn. The ...
The FTSE 100 and European stocks headed higher on Tuesday, while US stocks lost ground. It comes as traders' attention turns ...
1d
MoneyWeek on MSNAre these FTSE 100 pharmaceutical stocks worth a look?Pharmaceutical stocks are some of the biggest in the FTSE 100. The sector is threatened by tariffs, but some have posted encouraging results regardless.
London (UKX) +0.60% to 9,136, clocking a fresh record high. The IMF expects UK economic growth to outpace other major ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results